Publication | Closed Access

Development of a high-performance liquid chromatographic–mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine

Pharmaceutical ScienceMedicineRo 64-0802Mass SpectrometryAnti-influenza DrugAntiviral Drug DevelopmentAnalytical ChemistryAnimal PlasmaLiquid ChromatographyClinical ChemistryAntiviral DrugPharmacologyChromatographyDrug Analysis